litlas
ログインアカウント作成

Timo Vesikari

1968–2023 年に発表

106
論文数
21,364
被引用数
78
h 指数
106
i10 指数

被引用数

Timo Vesikari の年別被引用数1969 年: 被引用 3 件1972 年: 被引用 1 件1973 年: 被引用 1 件1974 年: 被引用 1 件1977 年: 被引用 1 件1978 年: 被引用 2 件1979 年: 被引用 1 件1980 年: 被引用 3 件1981 年: 被引用 1 件1983 年: 被引用 6 件1984 年: 被引用 10 件1985 年: 被引用 17 件1986 年: 被引用 35 件1987 年: 被引用 13 件1988 年: 被引用 20 件1989 年: 被引用 23 件1990 年: 被引用 24 件1991 年: 被引用 14 件1992 年: 被引用 15 件1993 年: 被引用 11 件1994 年: 被引用 10 件1995 年: 被引用 17 件1996 年: 被引用 23 件1997 年: 被引用 34 件1998 年: 被引用 37 件1999 年: 被引用 51 件2000 年: 被引用 80 件2001 年: 被引用 90 件2002 年: 被引用 114 件2003 年: 被引用 67 件2004 年: 被引用 73 件2005 年: 被引用 92 件2006 年: 被引用 137 件2007 年: 被引用 166 件2008 年: 被引用 157 件2009 年: 被引用 201 件2010 年: 被引用 234 件2011 年: 被引用 145 件2012 年: 被引用 182 件2013 年: 被引用 150 件2014 年: 被引用 181 件2015 年: 被引用 110 件2016 年: 被引用 135 件2017 年: 被引用 140 件2018 年: 被引用 154 件2019 年: 被引用 543 件2020 年: 被引用 457 件2021 年: 被引用 498 件2022 年: 被引用 306 件2023 年: 被引用 197 件2024 年: 被引用 366 件2025 年: 被引用 179 件1970〜1971 年は被引用が無いため表示していません1975〜1976 年は被引用が無いため表示していません1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,525 件、この内訳の 25%イギリス: 引用元論文 421 件、この内訳の 6.9%イタリア: 引用元論文 260 件、この内訳の 4.3%カナダ: 引用元論文 236 件、この内訳の 3.9%ベルギー: 引用元論文 227 件、この内訳の 3.7%フィンランド: 引用元論文 221 件、この内訳の 3.6%オーストラリア: 引用元論文 207 件、この内訳の 3.4%中国: 引用元論文 203 件、この内訳の 3.3%ドイツ: 引用元論文 192 件、この内訳の 3.2%フランス: 引用元論文 180 件、この内訳の 3%スペイン: 引用元論文 149 件、この内訳の 2.5%インド: 引用元論文 149 件、この内訳の 2.4%
0%25%その他 34.8%

機関

分野

  • Medicine71%
  • Biochemistry, Genetics and Molecular Biology9%
  • Agricultural and Biological Sciences8.1%
  • Immunology and Microbiology7%
  • Nursing1.4%
  • Social Sciences1.1%
  • その他2.4%

トピック

  • Viral gastroenteritis research and epidemiology12.3%
  • Respiratory viral infections research6.1%
  • Influenza Virus Research Studies4.4%
  • Herpesvirus Infections and Treatments4%
  • Probiotics and Fermented Foods4%
  • Viral Infections and Immunology Research3.9%
  • その他65.3%

共著者

全論文

検索で開く
  1. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

    著者: Himal Lal, Anthony L. Cunningham, Olivier Godeaux, Roman Chlíbek, Javier Díez‐Domingo, Shinn‐Jang Hwang, Myron J. Levin, Janet E. McElhaney, Airi Põder, Joan Puig‐Barberà, Timo Vesikari, Daisuke Watanabe, Lily Yin Weckx, Toufik Zahaf, Thomas C. Heineman - New England Journal of Medicine 2015 被引用: 1,417

  2. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

    著者: Anthony L. Cunningham, Himal Lal, Martina Kovac, Roman Chlíbek, Shinn‐Jang Hwang, Javier Díez‐Domingo, Olivier Godeaux, Myron J. Levin, Janet E. McElhaney, Joan Puig‐Barberà, Carline Vanden Abeele, Timo Vesikari, Daisuke Watanabe, Toufik Zahaf, Anitta Ahonen, Eugene Athan, José Fernando Barba‐Gómez, Laura Cámpora, Ferdinandus de Looze, H. Jackson Downey, Wayne Ghesquière, Iris Gorfinkel, Tiina Korhonen, Edward Leung, Shelly McNeil, Lidia Oostvogels, Lars Rombo, Jan Smetana, Lily Yin Weckx, W W Yeo, Thomas C. Heineman - New England Journal of Medicine 2016 被引用: 1,043

  3. Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

    著者: Steven Black, Uwe Nicolay, Timo Vesikari, Markus Knuf, Giuseppe Del Giudice, Giovanni Della Cioppa, Theodore F. Tsai, Ralf Clemens, Rino Rappuoli - The Pediatric Infectious Disease Journal 2011 被引用: 337

  4. Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

    著者: Anthony L. Cunningham, Thomas C. Heineman, Himal Lal, Olivier Godeaux, Roman Chlíbek, Shinn‐Jang Hwang, Janet E. McElhaney, Timo Vesikari, Charles P. Andrews, Won Suk Choi, Meral Esen, Hideyuki Ikematsu, Martina Kovac Choma, Karlis Pauksens, Stéphanie Ravault, Bruno Salaun, Tino F. Schwarz, Jan Smetana, Carline Vanden Abeele, Peter van Steen, Ilse Vastiau, Lily Yin Weckx, Myron J. Levin, ZOE-50/70 Study Group - The Journal of Infectious Diseases 2018 被引用: 200

  5. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials

    著者: Brian J. Ward, А. И. Макарков, Annie Séguin, Stéphane Pillet, Sonia Trépanier, Jiwanjeet K. Dhaliwall, Michael Libman, Timo Vesikari, Nathalie Landry - The Lancet 2020 被引用: 192

  6. Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

    著者: Ken Schmader, Myron J. Levin, J. W. Gnann, Shelly McNeil, Timo Vesikari, Robert F. Betts, S. Keay, Jon E. Stek, Nickoya D. Bundick, Shu-Jem Su, Yanli Zhao, Xiaoming Li, I. S. F. Chan, Paula W. Annunziato, Janie Parrino - Clinical Infectious Diseases 2012 被引用: 431

  7. Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

    著者: Guillermo M. Ruiz‐Palacios, Irene Pérez‐Schael, F. Raúl Velázquez, Héctor Abate, Thomas Breuer, Sue Ann Costa Clemens, Brigitte Cheuvart, Félix Espinoza, Paul Gillard, Bruce L. Innis, Yolanda Cervantes, Alexandre C. Linhares, Pío López, Mercedes Macías-Parra, Eduardo Ortega‐Barría, Vesta Richardson, Doris Maribel Rivera-Medina, Luis Rivera, Belén Salinas, Noris Pavía-Ruz, Jorge Salmerón, Ricardo Rüttimann, Juan Carlos Tinoco, Pilar Rubio, Ernesto Nuñez, M. Lourdes Guerrero, Juan Pablo Yarzábal, Silvia Damaso, Nadia Tornieporth, Xavier Sáez‐Llorens, Rodrigo Vergara, Timo Vesikari, Alain Bouckenooghe, Ralf Clemens, Béatrice De Vos, Miguel O’Ryan - New England Journal of Medicine 2006 被引用: 1,815

  8. Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

    著者: Timo Vesikari, David O. Matson, Penelope H. Dennehy, Pierre Van Damme, Mathuram Santosham, Zoe Rodriguez, Michael J. Dallas, Joseph F. Heyse, Michelle G. Goveia, Steven Black, Henry R. Shinefield, C D C Christie, Samuli Ylitalo, Robbin Itzler, Michele L. Coia, Matthew Onorato, Ben Adeyi, Gary S. Marshall, Leif Gothefors, Dirk Campens, Aino Karvonen, James Watt, Katherine L. O’Brien, Mark J. DiNubile, H. F. Clark, John W. Boslego, Paul A. Offit, Penny M. Heaton - New England Journal of Medicine 2006 被引用: 1,882

  9. Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children

    著者: Robert B. Belshe, Kathryn M. Edwards, Timo Vesikari, Steven V. Black, Robert Walker, Micki Hultquist, George Kemble, Edward M. Connor - New England Journal of Medicine 2007 被引用: 811

  10. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

    著者: Timo Vesikari, Aino Karvonen, Roman Prymula, Volker Schuster, JC Tejedor, Robert Cohen, François Meurice, H.H. Han, Silvia Damaso, Alain Bouckenooghe - The Lancet 2007 被引用: 641

  11. Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

    著者: Timo Vesikari, Adam Finn, Pierre Van Damme, Isabel Leroux‐Roels, Geert Leroux‐Roels, Nathan Segall, Azhar Toma, Gerald Vallieres, Ronnie Aronson, Dennis Reich, Samir Arora, Peter Ruane, Clancy Cone, Michael P. Manns, Catherine Cosgrove, Saul N. Faust, Maheshi Ramasamy, Nathalie Machluf, Johanna N. Spaans, Bebi Yassin-Rajkumar, David E. Anderson, Vlad Popovic, Francisco Díaz‐Mitoma, CONSTANT Study Group, Bruce Rankin, Mary Beth Manning, Carl Griffin, Amina Z. Haggag, Mark E Kutner, M. Turner, Barbara Rizzardi, Hayes Williams, Michael Levin, Hamilton Sah, Naveen Garg, Aino Forstén, Ilkka Seppä, Maija Rössi, Anitta Ahonen, Olli Henriksson, Benita Ukkonen, Satu Kokko, Outi Laajalahti, Pauliina Paavola - JAMA Network Open 2021 被引用: 61

  12. One-step quantitative RT-PCR for the detection of rotavirus in acute gastroenteritis

    著者: Shang‐Qin Zeng, Anne Halkosalo, Marjo Salminen, E. D. Szakal, Leena Puustinen, Timo Vesikari - Journal of Virological Methods 2008 被引用: 222

  13. Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

    著者: Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois, Mohamed El Idrissi, Lidia Oostvogels, Ferdinandus J. de Looze, Javier Díez‐Domingo, Thomas C. Heineman, Himal Lal, Janet E. McElhaney, Shelly McNeil, W W Yeo, Fernanda Tavares Da Silva, Anitta Ahonen, Thiago Junqueira Avelino‐Silva, José Fernando Barba‐Gómez, Johan Berglund, Carlos Brotons Cuixart, Covadonga Caso, Roman Chlíbek, Won Suk Choi, Anthony L. Cunningham, Maria Guiseppina Desole, Peter Eizenberg, Meral Esen, Emmanuelle Espié, P Gervais, Wayne Ghesquière, Olivier Godeaux, Iris Gorfinkel, David S.C. Hui, Shinn‐Jang Hwang, Tiina Korhonen, Martina Kovac, Edouard Ledent, Edward Leung, Myron J. Levin, Silvia Narejos Pérez, José Luiz Costa Neto, Karlis Pauksens, Airi Põder, María Luisa Rodríguez de la Pinta, Lars Rombo, Tino F. Schwarz, Jan Smetana, Tommaso Staniscia, Juan Carlos Tinoco, Azhar Toma, Ilse Vastiau, Timo Vesikari, Antonio Volpi, Daisuke Watanabe, Lily Yin Weckx, Toufik Zahaf - Vaccine 2019 被引用: 65

  14. Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial

    著者: Timo Vesikari, Joanne M. Langley, Nathan Segall, Brian J. Ward, Curtis Cooper, Guillaume Poliquin, Bruce R. Smith, Soren Gantt, Janet E. McElhaney, Marc Dionne, Pierre Van Damme, Isabel Leroux‐Roels, Geert Leroux‐Roels, Nathalie Machluf, Johanna N. Spaans, Bebi Yassin-Rajkumar, David E. Anderson, Vlad Popovic, Francisco Díaz‐Mitoma, Timo Vesikari, Joanne M. Langley, Soren Gantt, Marc Dionne, Janet E. McElhaney, Bruce Rankin, Carl Griffin, Mark Turner, Judith L. Kirstein, Barbara Rizzardi, Hayes Williams, Anitta Ahonen, Olli Henriksson, Benita Ukkonen, Marita Paassilta, Nathan Segall, Brian J. Ward, Curtis Cooper, Guillaume Poliquin, Bruce R. Smith, Pierre Van Damme, Isabel Leroux‐Roels, Geert Leroux‐Roels, Nathalie Machluf, Johanna N. Spaans, Bebi Yassin-Rajkumar, David E. Anderson, Vlad Popovic, Francisco Díaz‐Mitoma - The Lancet Infectious Diseases 2021 被引用: 72

  15. PreHevbrio: the first approved 3-antigen hepatitis B vaccine

    著者: Timo Vesikari, Joanne M. Langley, Vlad Popovic, Francisco Díaz‐Mitoma - Expert Review of Vaccines 2023 被引用: 17

  16. Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal Episodes

    著者: Tarja Ruuska, Timo Vesikari - Scandinavian Journal of Infectious Diseases 1990 被引用: 730

  17. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

    著者: David Greenberg, Patricia Hoover, Timo Vesikari, Christopher B. Peltier, David Hurley, Richard McFetridge, Michael J. Dallas, Jonathan Hartzel, Rocio D. Marchese, Beth-Ann Coller, Jon E. Stek, Chitrananda Abeygunawardana, Michael A. Winters, John E. MacNair, Narahari S. Pujar, Luwy Musey - Vaccine 2018 被引用: 107

  18. Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice

    著者: Kirsi Tamminen, Suvi Lappalainen, Leena Huhti, Timo Vesikari, Vesna Blazevic - PLoS ONE 2013 被引用: 103

  19. Primary Versus Secondary Failure After Varicella Vaccination

    著者: Paolo Bonanni, Anne A. Gershon, Michael D. Gershon, Andrea Kulcsár, Vassiliki Papaevangelou, Bernard Rentier, Catherine Sadzot‐Delvaux, Vytautas Usonis, Timo Vesikari, Catherine Weil-Olivier, Peter de Winter, Peter Wutzler - The Pediatric Infectious Disease Journal 2013 被引用: 85

  20. Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings

    著者: Joanne M. Langley, Véronique Bianco, Joseph B. Domachowske, Shabir A. Madhi, Sonia Stoszek, Khalequ Zaman, Agustin Bueso, Ana Ceballos, Luis Cousin, Ulises D’Andrea, Ilse Dieussaert, Janet A. Englund, Sanjay Gandhi, Olivier Gruselle, Gerco Haars, Lisa Jose, Nicola P. Klein, Amanda Leach, Koen Maleux, Thi Lien Anh Nguyen, Thanyawee Puthanakit, Peter Silas, Auchara Tangsathapornpong, Jamaree Teeratakulpisarn, Timo Vesikari, Rachel Cohen - The Journal of Infectious Diseases 2022 被引用: 38

  21. Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

    著者: Timo Vesikari, Markus Knuf, Peter Wutzler, Aino Karvonen, Dorothee Kieninger‐Baum, Heinz‐Josef Schmitt, Frank Baehner, Astrid Borkowski, Theodore F. Tsai, Ralf Clemens - New England Journal of Medicine 2011 被引用: 317

  22. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis

    著者: Vesna Blazevic, Suvi Lappalainen, Kirsi Nurminen, Leena Huhti, Timo Vesikari - Vaccine 2011 被引用: 143

  23. Rotavirus Vaccination Does Not Increase Type 1 Diabetes and May Decrease Celiac Disease in Children and Adolescents

    著者: Maria Hemming‐Harlo, Marja‐Leena Lähdeaho, Markku Mäki, Timo Vesikari - The Pediatric Infectious Disease Journal 2019 被引用: 75

  24. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

    著者: Timo Vesikari, Susanna Esposito, Roman Prymula, Ellen Ypma, Igor Kohl, Daniela Toneatto, Peter Dull, Alan Kimura - The Lancet 2013 被引用: 274